Recipharm Appoints New General Manager
News Apr 30, 2015
Recipharm has announced that Giorgio Bruno has been appointed General Manager of Recipharm Italia S.p.A. In this role, he will serve as CEO for all of Recipharm’s Italian operating companies which employ some 257 people at three sites and have revenues of €57m.
Dr Bruno has long established senior management experience from within the pharmaceutical industry, especially in the area of manufacturing. He has worked in both Italian and multinational pharmaceutical companies covering a wide range of disciplines.
In particular he has had responsibility for quality and manufacturing at such companies including Parke Davis, AstraZeneca and Corden Pharma. Dr Bruno also has strong industry knowledge and has held a number of positions within Italian based industry associations. He holds a Ph. D. in Pharmaceutical Chemistry and Technology from the University of Milan.
“Commenting on the appointment, Thomas Eldered, CEO of Recipharm remarked: “I am very pleased to welcome Dr Bruno to the Recipharm team. We are very fortunate to have been able to attract such a competent and highly experienced manager to this important position and I look forward to him bringing his expertise to bear across our Italian operations for which he is now responsible.”
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE
Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu VaccineNews
Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to vaccine development in the field of infectious diseases, announces that Innovate UK, the UK’s innovation agency, has awarded the company a grant of £979,318 to progress its universal flu vaccine programme through preclinical development.READ MORE
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018